Showing 2211-2220 of 2657 results for "".
- Oxurion Announces Preclinical Data on THR-687 for the Treatment of DMEhttps://modernod.com/news/oxurion-announces-preclinical-data-on-thr-687-for-the-treatment-of-dme-at-arvo/2480836/Oxurion presented preclinical data from a study evaluating THR-687 for treatment of diabetic macular edema (DME) at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting. Preclinical data shows THR-687's 
- RetinAI Receives FDA Clearance for Discovery Image Management Platform for Ophthalmologyhttps://modernod.com/news/retinai-receives-fda-clearance-for-discovery-image-management-platform-for-ophthalmology/2480826/RetinAI Medical AG announced it has received FDA 510(k) clearance for RetinAI Discovery, the company’s image and data management platform for interoperability across the clinical and clinical study ecosystems in ophthalmology. The Discovery platform can be
- Heidelberg Engineering Presents Various Scientific Innovations at ARVOhttps://modernod.com/news/heidelberg-engineering-presents-various-scientific-innovations-at-arvo/2480819/Heidelberg Engineering showcases its research capabilities at this year’s ARVO congress that takes place in Denver, Colorado, USA, from May 1–4. The team looks forward to reconnecting with the global research community after 2 years of solely virtual ARVO meetings, and to demonstratin
- Ocuphire Completes Last Clinical Trial Supporting the Planned 2022 NDA Submission of Nyxol for Reversal of Mydriasishttps://modernod.com/news/ocuphire-completes-last-clinical-trial-supporting-the-planned-2022-nda-submission-of-nyxol-for-reversal-of-mydriasis/2480812/Ocuphire Pharma announced positive results in the MIRA-4 pediatric safety trial investigating its product candidate Nyxol for the reversal of pharmacologically-induced mydriasis (dilation of pupil). The results demonstrated that Nyxol’s efficacy and safety in pediatric subjects 3-11 ye
- Allegro Ophthalmics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meetinghttps://modernod.com/news/allegro-ophthalmics-announces-new-scientific-data-to-be-presented-during-the-2022-arvo-annual-meeting/2480806/Allegro Ophthalmics announced that two scientific posters involving risuteganib, the company’s lead investigational compound in retina, will be presented during the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. ARVO 2022 will be held May 1-4, 2022 in
- Tarsus Presents Results of Two Studies Highlighting Demodex Blepharitis Patient Impact and Burden at the ASCRS 2022https://modernod.com/news/tarsus-presents-results-of-two-studies-highlighting-demodex-blepharitis-patient-impact-and-burden-at-the-ascrs-2022-annual-meeting/2480803/Tarsus Pharmaceuticals presented data from its Atlas Continuation study on the negative impacts to daily life and visual function, and preliminary findings from its Pandora study on pathogenic bacterial count, for patients with Demodex blepharitis at the American S
- Ocular Therapeutix to Present Preclinical and Clinical Data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meetinghttps://modernod.com/news/ocular-therapeutix-to-present-preclinical-and-clinical-data-at-the-2022-association-for-research-in-vision-and-ophthalmology-arvo-annual-meeting/2480797/Ocular Therapeutix announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting being held May 1-4 in Denver, Colorado and May 11-12 virtually. “At this year’s annual meeting, we are thrilled to be presenting c
- Alcon Announces Scientific Program at ASCRS 2022https://modernod.com/news/alcon-announces-scientific-program-at-ascrs-2022/2480782/Alcon will once again have a significant scientific presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2022 annual meeting, taking place April 22-26 in Washington, DC. Approximately 150 abstracts feature Alcon’s leading ophthalmic products and equipment—with m
- Shamir Announces Changes in Executive Leadershiphttps://modernod.com/news/shamir-announces-changes-in-executive-leadership/2480772/Shamir Insight announced that effective April 1, 2022, Pierson Ball, the company’s Director of Business and Strategic Development has been appointed as the new Vice President of Sales. Mr. Ball joined Shamir in 2007. “I am proud to have been part of the development and
- Actress Kate Walsh Teams Up with Alcon for Dry Eye Campaignhttps://modernod.com/news/actress-kate-walsh-teams-up-with-alcon-for-dry-eye-campaign/2480754/Alcon announced a partnership with actress Kate Walsh, best known for her roles in Grey’s Anatomy and Emily in Paris, to share her journey with dry eye around the launch of its Systane Complete Preservative-Free Lubricant Eye Drops. As part of the new